Julissa Milligan

American Enterprise Institute (AEI)

1150 17th Street, N.W.

Washington, DC 20036

United States

SCHOLARLY PAPERS

4

DOWNLOADS

232

SSRN CITATIONS

0

CROSSREF CITATIONS

6

Scholarly Papers (4)

1.

The Danger of Substandard Drugs in Emerging Markets: An Assessment of Basic Product Quality

Pharmacologia 3(2):46-51, March 2012
Number of pages: 6 Posted: 19 Oct 2013
Roger Bate, Lorraine Mooney and Julissa Milligan
American Enterprise Institute (AEI), Africa Fighting Malaria (UK) and American Enterprise Institute (AEI)
Downloads 81 (329,759)

Abstract:

Loading...

2.

Substandard and Falsified Anti-Tuberculosis Drugs: A Preliminary Field Analysis

The International Journal of Tuberculosis and Lung Disease, Volume 17, Number 3, March 2013, pp. 308-311(4)
Number of pages: 5 Posted: 03 Nov 2013
American Enterprise Institute (AEI), Pivit, Africa Fighting Malaria (US), Africa Fighting Malaria (UK) and American Enterprise Institute (AEI)
Downloads 65 (372,500)

Abstract:

Loading...

3.

Anti-Infective Medicine Quality: Analysis of Basic Product Quality by Approval Status and Country of Manufacture

Research and Reports in Tropical Medicine (3):57-61, 2012
Number of pages: 5 Posted: 29 Aug 2012 Last Revised: 17 Oct 2013
American Enterprise Institute (AEI), Africa Fighting Malaria (UK), Africa Fighting Malaria (US), American Enterprise Institute (AEI) and University of Ottawa - Department of Epidemiology and Community Medicine
Downloads 45 (440,796)

Abstract:

Loading...

stringent regulatory authority, World Health Organization prequalification program, product approval, counterfeit, India, China

4.

Dangerous Substandard Medicines: An Increasing Global Problem

AEI Health Policy Outlook No. 6
Number of pages: 7 Posted: 22 Oct 2013
Roger Bate, Julissa Milligan and Lorraine Mooney
American Enterprise Institute (AEI), American Enterprise Institute (AEI) and Africa Fighting Malaria (UK)
Downloads 41 (461,302)

Abstract:

Loading...